Clinical trial
The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of…
NCT00372177 · Biotectid GmbH, Industry · Completed
Key facts
| NCT number | NCT00372177 |
|---|---|
| Title | The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis |
| Official title | The Use of Anti-CD4 mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis (an Open Proof of Concept Study) |
| Lead sponsor | Biotectid GmbH, Industry |
| Collaborators | Technische Universität Dresden University of Leipzig |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis, Polyarthritis, Rheumatism, Autoimmune Disease, Inflammation |
| Intervention type | Radiation |
| Interventions | Fab-fragment of Anti-human CD4 |
| Enrollment | 5 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 6, 2006 |
| Last update posted | May 28, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: